nCAP Medical Attending FIME 2022

.

Dr. Jacques Chelly to Study Use of nCAP NeuroCuple(tm) for Pain Management after Hip Replacement Surgery

Read entire article here.

nCAP Medical participe au plus grand événement de santé du Moyen-Orient

nCAP Medical participera à l'Arab Health 2022 à l'invitation du World Trade Center, parmi plus de 3 500 exposants de plus de 60 pays du monde entier, du 24 au 27 janvier à Dubaï. L'exposition d'équipements médicaux rassemblera plus de 56 000 professionnels de la santé - y compris des administrateurs et des décideurs gouvernementaux en matière de soins de santé - afin d'apprendre, d'établir des réseaux et d'échanger. nCAP Medical rencontrera de nombreux responsables gouvernementaux en matière de soins de santé du monde entier dans le cadre de ses efforts continus pour réduire la douleur et l'utilisation de produits antidouleur addictifs. "Nous sommes honorés et enthousiastes à l'idée de présenter nos produits dans le cadre de l'envoyé du World...

Henry Ford's Invention Nation Features Kailo Patch

November 21, 2021 Henry Ford's Invention Nation with Mo Rocca reports on the Kailo Patch and its origins.

Drug-Free Pain Relief with Nanotechnology (Signal Relief White-paper)

Signal Relief has published a white paper.  This white paper covers health statistics of chronic pain in the United States and the approach Signal Relief employs to reduce pain. It will discuss the novel product in the Signal Relief portfolio, the Signal Relief Patch, designed to greatly improve comfort in those experiencing pain.  You can find this study here.

Novel Technological Advances Pain Relief (A study of the Kailo Patch)

Clarity Science LLC has published a study of the Kailo patch in Anesthesia & Pain Research ISSN 2639-846X. Using Nanotechnology to Improve Pain and Function with a Novel, Drug-Free, passive Pain-Relief Patch: An Interim Analysis,” represents preliminary outcomes from PREVENT (Pain Relief: Experience and Validity: Evaluating NanoTechnology), an IRB-approved, minimal risk, observational study.  Study can be found here

nCAP Medical Signed Technology Licensing Agreement with Caliber Med

November 1, 2019 nCAP Medical signed a licensing agreement with Caliber Med to further expand US Market's.  Caliber Med will utilize a variety of unique marketing techniques its developed from years in the direct-to-consumer space. This additional marketing capability will enhance the reach of the technology, as more and more people discover the amazing pain relief the technology brings.   You can learn more about their products at signalrelief.com and meetjovi.com The nCAP pain relief technology is a drug-free solution and easy to use, it's reusable and will work for years if taken care of and not misplaced.  

nCAP Medical Signed Technology Licensing Agreement with Pain Relief Technologies

March 28, 2018 nCAP Medical and Pain Relief Technologies sign a licensing agreement to expand the reach of nCAP's pain relief technology.  With this additional marketing capability it's hopeful that people around the world will discover the amazing relief the technology brings. The nCAP pain relief technology is a drug-free solution and easy to use, it's reusable and will work for years if taken care of and not misplaced. You can find this product at gokailo.com   "My employees and I are thrilled and grateful that we have a license to such an incredible technology from NCap Medical. The technology in the Kailo Pain Patch is a miracle of modern science and has the potential to change billions of lives. We do everything we...

nCap Medical LLC announces it has accumulated anecdotal evidence

OCTOBER 19, 2016 nCap Medical LLC announced it has accumulated anecdotal evidence that its non-invasive, Neurocuple(tm) technology has mitigated both acute and chronic pain without the need of opioids. The Company’s teaming partner, the Sidra Academic and Research Hospital, will conduct random, double blind studies. The Academic Teaching Faculty WCMC supports the Institution: Qatar Ministry of Health and its other partner institutions at Education City, Qatar (Georgetown University, Carnegie Mellon University, Weill-Cornell Medicine in Qatar, college of the North Atlantic and HEC, Paris). Dr. G. Russel Reiss, MD, Cardiothoracic Surgery,  formerly at the University of Utah, commented, “If the studies of the nCap nano-technology based material reveal efficaciousness, this could have one of the most significant impacts on the practice of...